Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial.

MLA

Gouëffic, Yann, et al. “Bare Metal Stent versus Paclitaxel Eluting Stent for Intermediate Length Femoropopliteal Arterial Lesions (BATTLE Trial): Study Protocol for a Randomized Controlled Trial.” Trials, vol. 15, Oct. 2014, p. 423. EBSCOhost, https://doi.org/10.1186/1745-6215-15-423.

APA

Gouëffic, Y., Kaladji, A., Guyomarch, B., Montagne, C., Fairier, D., Gestin, S., Riche, V.-P., Vent, P. A., Chaillou, P., Costargent, A., & Patra, P. (2014). Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial. Trials, 15, 423. https://doi.org/10.1186/1745-6215-15-423

Chicago

Gouëffic, Yann, Adrien Kaladji, Béatrice Guyomarch, Carine Montagne, Damien Fairier, Simon Gestin, Valéry-Pierre Riche, et al. 2014. “Bare Metal Stent versus Paclitaxel Eluting Stent for Intermediate Length Femoropopliteal Arterial Lesions (BATTLE Trial): Study Protocol for a Randomized Controlled Trial.” Trials 15 (October): 423. doi:10.1186/1745-6215-15-423.